As of Oct 21
| +0.20 / +3.67%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 11.38, with a high estimate of 24.00 and a low estimate of 8.00. The median estimate represents a +101.33% increase from the last price of 5.65.
The current consensus among 4 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.